As a result, shares of the company jumped 10.17 per cent to Rs 7,000 on BSE.
On NSE, the stock rose 10.19 per cent to Rs 6,998.
CFTRI had tested five samples sent by the Goa Food and Drug Administration (FDA) when Maggi was banned in June in the wake of findings in Uttar Pradesh and other states that the instant noodles brand had lead levels beyond permissible limits.
In June this year, Nestle had to take Maggi off the shelves after a few states decided to ban the noodles. FSSAI had also banned Maggi instant noodles terming them "unsafe and hazardous" for human consumption.